Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
Saved in:
| Title: | Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial. |
|---|---|
| Authors: | McIlroy, Graham1 (AUTHOR) g.w.mcilroy.1@bham.ac.uk, Lax, Siân1 (AUTHOR), Gaskell, Charlotte1 (AUTHOR), Jackson, Aimee1 (AUTHOR), Rhodes, Malcolm2 (AUTHOR), Seale, Tania3 (AUTHOR), Fox, Sonia1 (AUTHOR), Hopkins, Lousie1 (AUTHOR), Okosun, Jessica4 (AUTHOR), Barrington, Sally F.5 (AUTHOR), Ringshausen, Ingo6 (AUTHOR), Ramsay, Alan G.7 (AUTHOR), Calaminici, Maria8 (AUTHOR), Linton, Kim3,9 (AUTHOR), Bishton, Mark10,11 (AUTHOR) |
| Source: | BMC Cancer. 3/25/2024, Vol. 24 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 176250448 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22McIlroy%2C+Graham%22">McIlroy, Graham</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> g.w.mcilroy.1@bham.ac.uk</i><br /><searchLink fieldCode="AR" term="%22Lax%2C+Siân%22">Lax, Siân</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gaskell%2C+Charlotte%22">Gaskell, Charlotte</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jackson%2C+Aimee%22">Jackson, Aimee</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rhodes%2C+Malcolm%22">Rhodes, Malcolm</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Seale%2C+Tania%22">Seale, Tania</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fox%2C+Sonia%22">Fox, Sonia</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hopkins%2C+Lousie%22">Hopkins, Lousie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Okosun%2C+Jessica%22">Okosun, Jessica</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barrington%2C+Sally+F%2E%22">Barrington, Sally F.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ringshausen%2C+Ingo%22">Ringshausen, Ingo</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ramsay%2C+Alan+G%2E%22">Ramsay, Alan G.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Calaminici%2C+Maria%22">Calaminici, Maria</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Linton%2C+Kim%22">Linton, Kim</searchLink><relatesTo>3,9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bishton%2C+Mark%22">Bishton, Mark</searchLink><relatesTo>10,11</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 3/25/2024, Vol. 24 Issue 1, p1-13. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=176250448 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-024-12112-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 1 Titles: – TitleFull: Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: McIlroy, Graham – PersonEntity: Name: NameFull: Lax, Siân – PersonEntity: Name: NameFull: Gaskell, Charlotte – PersonEntity: Name: NameFull: Jackson, Aimee – PersonEntity: Name: NameFull: Rhodes, Malcolm – PersonEntity: Name: NameFull: Seale, Tania – PersonEntity: Name: NameFull: Fox, Sonia – PersonEntity: Name: NameFull: Hopkins, Lousie – PersonEntity: Name: NameFull: Okosun, Jessica – PersonEntity: Name: NameFull: Barrington, Sally F. – PersonEntity: Name: NameFull: Ringshausen, Ingo – PersonEntity: Name: NameFull: Ramsay, Alan G. – PersonEntity: Name: NameFull: Calaminici, Maria – PersonEntity: Name: NameFull: Linton, Kim – PersonEntity: Name: NameFull: Bishton, Mark IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 03 Text: 3/25/2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |